Learn More
Description
Reacts with a 170-180kDa transmembrane glycoprotein (P-glycoprotein), a product of the multidrug resistance-1 (MDR1) gene. This glycoprotein is expressed on MDR positive cells and has been reported to be expressed on many normal tissues, such as adrenal glands and endothelium, in the brain and skin. P-glycoprotein is known to impart drug resistance to cells by pumping many anti-cancer drugs out of the cytoplasm. 17F9 antibody binds to the surface of the viable, unfixed MDR+ cell line, PMG-Y (please inquire), and is able to partially block the binding of UIC2 antibody (another MDR-specific monoclonal antibody). Immunoprecipitation application is reported, but not routinely tested in house.
Host Species: Mouse
Clone: 17F9
Isotype: IgG2b, κ
Cross Reactivity: Human
Flow Cytometry
Specifications
Specifications
| Antigen | P-glycoprotein |
| Applications | Flow Cytometry |
| Classification | Monoclonal |
| Clone | 17F9 |
| Conjugate | FITC |
| Description | CD243; ABCB1; ABC20; CLCS; GP170; MDR1; P-GP; PGY1 |
| Formulation | Aqueous buffered solution containing BSA and ≤0.09% sodium azide. |
| Host Species | Mouse |
| Immunogen | Human MDR1 Transfected Cell Line |
| Purification Method | Affinity Purified |
| Show More |
For Research Use Only.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.